Aiguo Liu

2.7k total citations · 2 hit papers
104 papers, 1.8k citations indexed

About

Aiguo Liu is a scholar working on Molecular Biology, Oncology and Sensory Systems. According to data from OpenAlex, Aiguo Liu has authored 104 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 28 papers in Oncology and 10 papers in Sensory Systems. Recurrent topics in Aiguo Liu's work include Cytokine Signaling Pathways and Interactions (10 papers), Hearing, Cochlea, Tinnitus, Genetics (9 papers) and Vestibular and auditory disorders (7 papers). Aiguo Liu is often cited by papers focused on Cytokine Signaling Pathways and Interactions (10 papers), Hearing, Cochlea, Tinnitus, Genetics (9 papers) and Vestibular and auditory disorders (7 papers). Aiguo Liu collaborates with scholars based in China, United States and Canada. Aiguo Liu's co-authors include Hanxiao Xu, Kongming Wu, Jiayuh Lin, Xun Yuan, Mengke Niu, Pui‐Kai Li, Dechao Jiao, Li Lin, Zhengang Peng and Chenglong Li and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Blood.

In The Last Decade

Aiguo Liu

90 papers receiving 1.8k citations

Hit Papers

CD44 as a tumor biomarker and therapeutic target 2020 2026 2022 2024 2020 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CD44 as a tumor biomarker and therapeutic target
    2020 266 citations Aiguo Liu et al. profile →
  2. Tumor organoids: applications in cancer modeling and potentials in precision medicine
    2022 161 citations Aiguo Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aiguo Liu China 23 856 657 377 201 179 104 1.8k
Dong Cheng China 26 956 1.1× 513 0.8× 250 0.7× 231 1.1× 133 0.7× 79 1.8k
Qiong Zhou China 25 975 1.1× 334 0.5× 205 0.5× 142 0.7× 97 0.5× 88 2.0k
Mireille Van Gele Belgium 33 1.1k 1.2× 833 1.3× 262 0.7× 490 2.4× 131 0.7× 65 2.7k
Jingliang Cheng China 22 779 0.9× 236 0.4× 231 0.6× 119 0.6× 146 0.8× 110 1.5k
Jing Sun China 29 1.4k 1.7× 214 0.3× 393 1.0× 261 1.3× 91 0.5× 120 2.5k
Ju Chen China 16 940 1.1× 381 0.6× 198 0.5× 297 1.5× 132 0.7× 64 1.7k
Yan Lu China 25 999 1.2× 299 0.5× 377 1.0× 142 0.7× 102 0.6× 92 1.9k
Xiang Lin China 24 826 1.0× 341 0.5× 210 0.6× 552 2.7× 90 0.5× 108 2.4k
Lulu Liu China 28 945 1.1× 490 0.7× 264 0.7× 341 1.7× 101 0.6× 125 2.2k
Qi Cao China 21 643 0.8× 334 0.5× 246 0.7× 435 2.2× 54 0.3× 43 1.8k

Countries citing papers authored by Aiguo Liu

Since Specialization
Citations

This map shows the geographic impact of Aiguo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiguo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiguo Liu more than expected).

Fields of papers citing papers by Aiguo Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiguo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiguo Liu. The network helps show where Aiguo Liu may publish in the future.

Co-authorship network of co-authors of Aiguo Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Aiguo Liu. A scholar is included among the top collaborators of Aiguo Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiguo Liu. Aiguo Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Aiguo, Shuang Deng, Sitong Zhang, et al.. (2025). Application of Light-Responsive Nanomaterials in Bone Tissue Engineering. Pharmaceutics. 17(1). 98–98. 4 indexed citations
2.
3.
Xie, Li, et al.. (2024). Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma. Cell Cycle. 23(5). 537–554. 2 indexed citations
4.
Fang, Yongjun, Jie Yan, Ju Gao, et al.. (2024). The Prognostic and Risk Factors for Children With High‐Risk Mature B‐Cell Non‐Hodgkin's Lymphoma: A Retrospective Multicenter Study. Cancer Medicine. 13(21). e70309–e70309. 1 indexed citations
5.
Liu, Aiguo, et al.. (2021). The relationship between water‐holding capacities of soybean–whey mixed protein and ice crystal size for ice cream. Journal of Food Process Engineering. 44(7). 12 indexed citations
6.
Yang, Yan, Lili Ding, Qi Zhou, et al.. (2020). Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells. Cancer Cell International. 20(1). 9–9. 38 indexed citations
7.
Wang, Fang, Ping Zhang, Yao Cheng, et al.. (2018). Patients’ sense of responsibility to healthcare providers and its predictors: A national cross-sectional survey in China. PLoS ONE. 13(12). e0207361–e0207361. 1 indexed citations
8.
Ren, Huihui, Zhenggang Wang, Ping Zhang, et al.. (2017). Hearing Loss in Type 2 Diabetes in Association with Diabetic Neuropathy. Archives of Medical Research. 48(7). 631–637. 30 indexed citations
9.
10.
Zhang, Linzhong, Guomin Han, Juan Li, et al.. (2015). PLNlncRbase: A resource for experimentally identified lncRNAs in plants. Gene. 573(2). 328–332. 61 indexed citations
11.
Liu, Aiguo, Cameron Williams, Hui Xiao, et al.. (2015). Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors. Bioorganic & Medicinal Chemistry. 23(6). 1348–1355. 12 indexed citations
12.
Liu, Aiguo, Yan Liu, Zhigang Jin, et al.. (2012). XZH-5 Inhibits STAT3 Phosphorylation and Enhances the Cytotoxicity of Chemotherapeutic Drugs in Human Breast and Pancreatic Cancer Cells. PLoS ONE. 7(10). e46624–e46624. 27 indexed citations
13.
Lin, Li, Aiguo Liu, Zhengang Peng, et al.. (2011). STAT3 Is Necessary for Proliferation and Survival in Colon Cancer–Initiating Cells. Cancer Research. 71(23). 7226–7237. 251 indexed citations
14.
Liu, Yan, Aiguo Liu, Huameng Li, Chenglong Li, & Jiayuh Lin. (2011). Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor–Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells. Cancer Prevention Research. 4(8). 1296–1305. 54 indexed citations
15.
Liu, Aiguo, Yan Liu, Pui‐Kai Li, Chenglong Li, & Jiayuh Lin. (2011). LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells.. PubMed. 31(6). 2029–35. 27 indexed citations
16.
Liu, Aiguo, Yan Liu, Zhenghu Xu, et al.. (2011). Novel small molecule, XZH‐5, inhibits constitutive and interleukin‐6‐induced STAT3 phosphorylation in human rhabdomyosarcoma cells. Cancer Science. 102(7). 1381–1387. 23 indexed citations
17.
Liu, Aiguo, Li Lin, Chang‐Ching Wei, et al.. (2011). Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice. Investigational New Drugs. 30(3). 916–926. 49 indexed citations
18.
Liu, Aiguo. (2010). Preliminary study on the method for determination of caseinomacropeptides. Food Science and Technology International. 1 indexed citations
19.
Liu, Yanlin, et al.. (2009). Application of lead acetate test paper in the screen of low-H2 S-producing yeast strains.. Journal of Northwest A&F University. 37(1). 225–234. 1 indexed citations
20.
Liu, Aiguo. (2004). EFFECTS OF LOSARTAN AND ENALAPRIL ON THE RENAL FUNCTION IN OLD PATIENTS WITH HYPERTENSION. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dong Cheng Breakdown of academic impact, for papers by Qiong Zhou Breakdown of academic impact, for papers by Mireille Van Gele Breakdown of academic impact, for papers by Jingliang Cheng Breakdown of academic impact, for papers by Jing Sun Breakdown of academic impact, for papers by Ju Chen Breakdown of academic impact, for papers by Yan Lu Breakdown of academic impact, for papers by Xiang Lin Breakdown of academic impact, for papers by Lulu Liu Breakdown of academic impact, for papers by Qi Cao
Rankless by CCL
2026